Korean Tickers
KRX in English
HomeMarketsStocksFinancialsGuide
NewsfeedInsightsEarningsBroker research
AI Value Chain
X
Korean Tickers
KRX in English
HomeMarketsStocksFinancialsGuide
NewsfeedInsightsEarningsBroker research
AI Value Chain
XSign in

Market Pulse

Daily · Nov 5, 2026 · data.go.kr + ECOS
KOSPI
5,383.80
-300.00 (-5.28%)
KOSDAQ
678.41
-36.54 (-5.11%)
KOSPI 200
837.78
-51.47 (-5.79%)
USD/KRW
1,342.10
Home›Reports›000100
000100KOSDAQ·Nov 06, 2025

Excluding Base Effects, Results Solid

YUHAN CORPORATIONKB SecuritiesHarry Kim
Read original PDF ↗
Source
KB Securities
Type
Company analysis
Language
English
Rating
Buy
Target price
KRW 165,000
Collected
May 06, 2026
The full report is published by KB Securities. Korean Tickers provides its source link and metadata.

More research on 000100

Lazertinib royalty growth disappoints; out-licensing potential remainsMirae Asset Securities · Oct 29, 2026Lazcluze uptake likely to accelerate; growing out-licensing potentialMirae Asset Securities · Jul 31, 2026Initiating Coverage: Royalties Should Begin in EarnestKB Securities · May 27, 2026Focus on pace of lazertinib growth and out-licensing potentialMirae Asset Securities · Feb 12, 2026API exports and licensing income drive earnings surpriseMirae Asset Securities · Jul 31, 2025Earnings miss due to absence of milestone income, but API growth stands outMirae Asset Securities · May 12, 2025
All reports for 000100 →

Advertisement

Korean Tickers·Research reference for Korean listed companies.
Prices use KIS quote snapshots with data.go.kr daily fallback. Financials use DART; macro data uses ECOS.·Market data is informational and not investment advice.
KIS snapshots are refreshed every 30 minutes and are not a streaming quote feed.·Sources
TermsRefundsDisclaimerPrivacy